24 research outputs found
Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission
BackgroundExplore the efficacy and safety of donor-derived CLL-1 chimeric antigen receptor T-cell therapy (CAR-T) for relapsed/refractory acute myeloid leukemia (R/R AML) bridging to allogeneic hematopoietic stem cell transplantation (allo-HSCT) after remission.Case presentationAn adult R/R AML patient received an infusion of donor-derived CLL-1 CAR-T cells, and the conditioning regimen bridging to allo-HSCT was started immediately after remission on day 11 after CAR-T therapy upon transplantation. Then, routine post-HSCT monitoring of blood counts, bone marrow (BM) morphology, flow cytometry, graft-versus-host disease (GVHD) manifestations, and chimerism status were performed.ResultAfter CAR-T therapy, cytokine release syndrome was grade 1. On day 11 after CAR-T therapy, the BM morphology reached complete remission (CR), and the conditioning regimen bridging to allo-HSCT started. Leukocyte engraftment, complete donor chimerism, and platelet engraftment were observed on days +18, +23, and +26 post-allo-HSCT, respectively. The BM morphology showed CR and flow cytometry turned negative on day +23. The patient is currently at 4 months post-allo-HSCT with BM morphology CR, negative flow cytometry, complete donor chimerism, and no extramedullary relapse/GVHD.ConclusionDonor-derived CLL-1 CAR-T is an effective and safe therapy for R/R AML, and immediate bridging to allo-HSCT after remission may better improve the long-term prognosis of R/R AML
Allicin disrupts cardiac Cav1.2 channels via trafficking
Context: Allicin is a potential antiarrhythmic agent. The antiarrhythmic properties of allicin rely on its blockade of various cardiac ion channels. The l-type calcium (Cav1.2) channel provides a pivotal substrate for cardiac electrophysiologic activities. The mechanism of allicin on Cav1.2 remains unclear. Objective: This study evaluated the potential of allicin on the synthesis and trafficking of Cav1.2 channels. Materials and methods: Primary cardiomyocytes (CMs) from neonatal Sprague-Dawley (SD) rats were exposed to allicin (0, 0.0001, 0.001, 0.01, 0.1, 1, 10, 100 μg/mL) for 24 and 48 h. The CellTiter-Glo assay was performed to measure CM viability. Western blot with grayscale analysis and confocal laser scanning microscopy were used to evaluate the effects of allicin on the synthesis and trafficking of Cav1.2 channel proteins in primary CMs. Results: There was no significant difference in apoptotic toxicity from the actual cell viability (p > 0.05) in any group (0, 0.0001, 0.001, 0.01, 0.1, 1, 10, 100 μg/mL allicin), except that viability in the 0.001 and 0.01 μg/mL groups at 24 h were significantly greater (137.37 and 135.96%) (p < 0.05). Western blot with grayscale analysis revealed no substantial inhibition by allicin of the synthesis of Cav1.2 proteins. Confocal laser scanning microscopy revealed trafficking dysfunction of Cav1.2 channels caused by allicin in primary CMs. Conclusion: This study is the first to demonstrate that allicin inhibits cardiac Cav1.2 channels by disrupting trafficking, possibly mediating its antiarrhythmic benefits. Therefore, allicin might serve as a new antiarrhythmic agent in the future
Generating Image Descriptions of Rice Diseases and Pests Based on DeiT Feature Encoder
We propose a DeiT (Data-Efficient Image Transformer) feature encoder-based algorithm for identifying disease types and generating relevant descriptions of diseased crops. It solves the scarcity problem of the image description algorithm applied in agriculture. We divided the original image into a sequence of image patches to fit the input form of the DeiT encoder, which was distilled by RegNet. Then, we used the Transformer decoder to generate descriptions. Compared to “CNN + LSTM” models, our proposed model is entirely convolution-free and has high training efficiency. On the Rice2k dataset created by us, the model achieved a 47.3 BLEU-4 score, 65.0 ROUGE_L score, and 177.1 CIDEr score. The extensive experiments demonstrate the effectiveness and the strong robustness of our model. It can be better applied to automatically generate descriptions of similar crop disease characteristics
Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6
Glucolipotoxicity is one of the critical causal factors of diabetic complications. Whether mesenchymal stem cells (MSCs) have effects on glucolipotoxicity in human umbilical vein endothelial cells (HUVECs) and mechanisms involved are unclear. Thirty mM glucose plus 100 μM palmitic acid was used to induce glucolipotoxicity in HUVECs. MSCs and HUVECs were co-cultured at the ratio of 1:5 via Transwell system. The mRNA expressions of inflammatory factors were detected by RT-qPCR. The productions of reactive oxygen species (ROS), cell cycle and apoptosis were analyzed by flow cytometry. The tumor necrosis factor-α stimulated protein 6 (TSG-6) was knockdown in MSCs by RNA interference. High glucose and palmitic acid remarkably impaired cell viability and tube formation capacity, as well as increased the mRNA expression of inflammatory factors, ROS levels, and cell apoptosis in HUVECs. MSC co-cultivation ameliorated these detrimental effects in HUVECs, but no effect on ROS production. Moreover, TSG-6 was dramatically up-regulated by high glucose and fatty acid stimulation in both MSCs and HUVECs. TSG-6 knockdown partially abolished the protection mediated by MSCs. MSCs had protective effects on high glucose and palmitic acid induced glucolipotoxicity in HUVECs, and TSG-6 secreted by MSCs was likely to play an important role in this process
Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6
Glucolipotoxicity is one of the critical causal factors of diabetic complications. Whether mesenchymal stem cells (MSCs) have effects on glucolipotoxicity in human umbilical vein endothelial cells (HUVECs) and mechanisms involved are unclear. Thirty mM glucose plus 100 μM palmitic acid was used to induce glucolipotoxicity in HUVECs. MSCs and HUVECs were co-cultured at the ratio of 1:5 via Transwell system. The mRNA expressions of inflammatory factors were detected by RT-qPCR. The productions of reactive oxygen species (ROS), cell cycle and apoptosis were analyzed by flow cytometry. The tumor necrosis factor-α stimulated protein 6 (TSG-6) was knockdown in MSCs by RNA interference. High glucose and palmitic acid remarkably impaired cell viability and tube formation capacity, as well as increased the mRNA expression of inflammatory factors, ROS levels, and cell apoptosis in HUVECs. MSC co-cultivation ameliorated these detrimental effects in HUVECs, but no effect on ROS production. Moreover, TSG-6 was dramatically up-regulated by high glucose and fatty acid stimulation in both MSCs and HUVECs. TSG-6 knockdown partially abolished the protection mediated by MSCs. MSCs had protective effects on high glucose and palmitic acid induced glucolipotoxicity in HUVECs, and TSG-6 secreted by MSCs was likely to play an important role in this process
Protein Coronas Derived from Mucus Act as Both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes
The epithelial mucosa is a key biological barrier faced
by gastrointestinal,
intraoral, intranasal, ocular, and vaginal drug delivery. Ligand-modified
nanoparticles demonstrate excellent ability on this process, but their
efficacy is diminished by the formation of protein coronas (PCs) when
they interact with biological matrices. PCs are broadly implicated
in affecting the fate of NPs in vivo and in vitro, yet few studies
have investigated PCs formed during interactions of NPs with the epithelial
mucosa, especially mucus. In this study, we constructed transferrin
modified NPs (Tf-NPs) as a model and explored the mechanisms and effects
that epithelial mucosa had on PCs formation and the subsequent impact
on the transcellular transport of Tf-NPs. In mucus-secreting cells,
Tf-NPs adsorbed more proteins from the mucus layers, which masked,
displaced, and dampened the active targeting effects of Tf-NPs, thereby
weakening endocytosis and transcellular transport efficiencies. In
mucus-free cells, Tf-NPs adsorbed more proteins during intracellular
trafficking, which enhanced transcytosis related functions. Inspired
by soft coronas and artificial biomimetic membranes, we used mucin
as an “active PC” to precoat Tf-NPs (M@Tf-NPs), which
limited the negative impacts of “passive PCs” formed
during interface with the epithelial mucosa and improved favorable
routes of endocytosis. M@Tf-NPs adsorbed more proteins associated
with endoplasmic reticulum-Golgi functions, prompting enhanced intracellular
transport and exocytosis. In summary, mucus shielded against the absorption
of Tf-NPs, but also could be employed as a spear to break through
the epithelial mucosa barrier. These findings offer a theoretical
foundation and design platform to enhance the efficiency of oral-administered
nanomedicines
Protein Coronas Derived from Mucus Act as Both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes
The epithelial mucosa is a key biological barrier faced
by gastrointestinal,
intraoral, intranasal, ocular, and vaginal drug delivery. Ligand-modified
nanoparticles demonstrate excellent ability on this process, but their
efficacy is diminished by the formation of protein coronas (PCs) when
they interact with biological matrices. PCs are broadly implicated
in affecting the fate of NPs in vivo and in vitro, yet few studies
have investigated PCs formed during interactions of NPs with the epithelial
mucosa, especially mucus. In this study, we constructed transferrin
modified NPs (Tf-NPs) as a model and explored the mechanisms and effects
that epithelial mucosa had on PCs formation and the subsequent impact
on the transcellular transport of Tf-NPs. In mucus-secreting cells,
Tf-NPs adsorbed more proteins from the mucus layers, which masked,
displaced, and dampened the active targeting effects of Tf-NPs, thereby
weakening endocytosis and transcellular transport efficiencies. In
mucus-free cells, Tf-NPs adsorbed more proteins during intracellular
trafficking, which enhanced transcytosis related functions. Inspired
by soft coronas and artificial biomimetic membranes, we used mucin
as an “active PC” to precoat Tf-NPs (M@Tf-NPs), which
limited the negative impacts of “passive PCs” formed
during interface with the epithelial mucosa and improved favorable
routes of endocytosis. M@Tf-NPs adsorbed more proteins associated
with endoplasmic reticulum-Golgi functions, prompting enhanced intracellular
transport and exocytosis. In summary, mucus shielded against the absorption
of Tf-NPs, but also could be employed as a spear to break through
the epithelial mucosa barrier. These findings offer a theoretical
foundation and design platform to enhance the efficiency of oral-administered
nanomedicines